Various studies investigated the association of IFN-inducible protein 10 (IP-10) with the IFN signature and disease activity in SLE [8–11], and a recent metaanalysis concluded that serum levels of IP-10 reflected systemic activity whereas urine levels could be useful for discriminating active LN [3]. Here, IFNA1 is linked to systemic lupus erythematosus.